Great Point Partners
PE
2003
$1 699 M
Greenwich, Connecticut, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Great Point Partners was founded in 2003 with a vision of helping growing health care companies achieve their full potential while improving global health care.
Great Point has two distinct teams managing separate but highly complementary investment strategies - lower middle market growth buyout funds investing in private health care companies and a hedge fund investing in public life sciences companies. We recognize the tremendous synergy gained by investing in both private and public companies across the health care spectrum, and companies choose to work with us because of our health care expertise, industry contacts, and focus on helping strong management teams grow their businesses.
With offices in Connecticut and London, we are led by a team of Managing Directors with a collective 90+ years of investment experience, supported by over 30 professionals. Our CEO Advisory Board is comprised of leading health care industry executives who have built successful businesses, and our Medical Advisory Board of physicians and scientists who are luminaries in their fields.
Industry
Region of investment
Great Point Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Great Point Partners Private Equity Fund I
|
Private Equity (PE)
|
Biotechnology
Financial Services
Fintech
Healthcare Services
Medical Devices
Infrastructure
HealthTech
|
Series B
|
North America
|
$5-10 m
|
$156 M
|
November 2003
|
|
Great Point Partners Private Equity Fund II
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
Medical Devices
Technology
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$215 M
|
October 2013
|
|
Great Point Partners IV, L.P.
|
Private Equity (PE)
|
Healthcare Services
Medical Devices
Technology
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1000 M
|
October 2023
|
